Astuti et al. 2022. Program Death Ligan-1 (PD-L1) Expression in Invasif Breast Carcinoma of No Special Type. International Journal of Sciences: Basic and Applied Research (IJSBAR). 61, 1 (Feb. 2022), 331–337.